Vanguard Group Inc Teva Pharmaceutical Industries LTD Transaction History

Vanguard Group Inc

  • $5.46 Trillion
  • Q3 2024

A detailed history of Vanguard Group Inc transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Vanguard Group Inc holds 844,188 shares of TEVA stock, worth $14.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
844,188
Previous 826,563 2.13%
Holding current value
$14.5 Million
Previous $13.4 Million 13.26%
% of portfolio
0.0%
Previous 0.0%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$15.81 - $18.96 $278,651 - $334,170
17,625 Added 2.13%
844,188 $15.2 Million
Q2 2024

Aug 13, 2024
BUY
$12.78 - $17.4 $13,112 - $17,852
1,026 Added 0.12%
826,563 $13.4 Million
Q1 2024

May 10, 2024
BUY
$10.67 - $14.43 $299,517 - $405,064
28,071 Added 3.52%
825,537 $11.6 Million
Q3 2023

Nov 14, 2023
BUY
$7.48 - $10.7 $211,100 - $301,975
28,222 Added 3.67%
797,466 $8.13 Million
Q1 2023

May 15, 2023
SELL
$8.36 - $11.37 $6,855 - $9,323
-820 Reduced 0.11%
769,244 $6.81 Million
Q3 2022

Nov 14, 2022
BUY
$6.86 - $11.95 $94,571 - $164,742
13,786 Added 1.82%
770,064 $6.22 Million
Q2 2022

Aug 12, 2022
BUY
$7.38 - $10.4 $456,393 - $643,156
61,842 Added 8.91%
756,278 $5.69 Million
Q1 2022

May 13, 2022
SELL
$7.33 - $9.39 $83,210 - $106,595
-11,352 Reduced 1.61%
694,436 $6.52 Million
Q4 2021

Feb 14, 2022
SELL
$7.9 - $10.19 $1.23 Million - $1.58 Million
-155,469 Reduced 18.05%
705,788 $5.65 Million
Q3 2021

Nov 12, 2021
BUY
$8.38 - $10.18 $130,409 - $158,421
15,562 Added 1.84%
861,257 $8.39 Million
Q2 2021

Aug 13, 2021
BUY
$9.9 - $11.56 $8.37 Million - $9.78 Million
845,695 New
845,695 $8.37 Million

Others Institutions Holding TEVA

# of Institutions
640
Shares Held
580M
Call Options Held
19.6M
Put Options Held
6.77M
View Full List

About TEVA PHARMACEUTICAL INDUSTRIES LTD

TEVA Quotes by TradingView
  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $19.1B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email